Cerenome, Inc.
CNSY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001095981
No open-market purchases or sales by Cerenome, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.89M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Cerenome, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- −17 vs. Q1 2023
- Shares held
- 101.7K
- −33.4K (−24.7%) vs. Q1 2023Converted for a 1-for-15 split
- Total value
- $205.5K
- −$382.8K (−65.1%) vs. Q1 2023
- New holders
- 0
- 2 more added
- Sold out
- 17
- 1 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $2.89M |
| Q1 2026 | 25 | $1.49M |
| Q4 2025 | 27 | $5.92M |
| Q3 2025 | 23 | $3.57M |
| Q2 2025 | 19 | $131.6K |
| Q1 2025 | 17 | $368.7K |
| Q4 2024 | 11 | $779.9K |
| Q3 2024 | 11 | $980.5K |
| Q2 2024 | 12 | $1.00M |
| Q1 2024 | 10 | $181.8K |
| Q4 2023 | 12 | $247.4K |
| Q3 2023 | 12 | $117.9K |
| Q2 2023 | 7 | $205.5K |
| Q1 2023 | 25 | $588.3K |
| Q4 2022 | 30 | $872.1K |
| Q3 2022 | 28 | $1.58M |
| Q2 2022 | 26 | $1.93M |
| Q1 2022 | 23 | $3.26M |
| Q4 2021 | 24 | $2.03M |
| Q3 2021 | 18 | $2.48M |
| Q2 2021 | 22 | $4.11M |
| Q1 2021 | 18 | $717.0K |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Cerenome, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 72,861 | $147.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Geode Capital Management, LLC | 17,007 | $34.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| BlackRock Inc. | 6,960 | $14.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Tower Research Capital LLC (TRC) | 4,731 | $9.56K | 0.00% | +4,127+683.6% | AddedConverted for a 1-for-15 split |
| Advisor Group Holdings, Inc. | 133 | $268 | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Wells Fargo & Company | 18 | $36 | 0.00% | +2+15.4% | AddedConverted for a 1-for-15 split |
| Group One Trading, L.P. | 1 | $2 | 0.00% | −0−28.6% | ReducedConverted for a 1-for-15 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,621−100.0% | Sold outConverted for a 1-for-15 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −4,645−100.0% | Sold outConverted for a 1-for-15 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,839−100.0% | Sold outConverted for a 1-for-15 split |
| State Street Corp | 0 | $0 | 0.00% | −2,294−100.0% | Sold outConverted for a 1-for-15 split |
| Great Valley Advisor Group, Inc. | 0 | $0 | 0.00% | −2,240−100.0% | Sold outConverted for a 1-for-15 split |
| Creative Planning | 0 | $0 | 0.00% | −2,236−100.0% | Sold outConverted for a 1-for-15 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −2,140−100.0% | Sold outConverted for a 1-for-15 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,563−100.0% | Sold outConverted for a 1-for-15 split |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −815−100.0% | Sold outConverted for a 1-for-15 split |
| FMR LLC | 0 | $0 | 0.00% | −133−100.0% | Sold outConverted for a 1-for-15 split |
| Umb Bank N A | 0 | $0 | 0.00% | −4−100.0% | Sold outConverted for a 1-for-15 split |
| UBS Group AG | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-15 split |
| Morgan Stanley | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-15 split |
| Barclays PLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-15 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-15 split |
| Financial Perspectives, Inc | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-15 split |
| Allworth Financial LP | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-15 split |
| Householder Group Estate & Retirement Specialist, LLC | – | – | – | – | Not filed |